“Working with life science companies is not like serving other industries. There are myriad legal and financial eccentricities – accounting for multiple financing sources makes accounting especially complex, for instances and protecting intellectual property is key. Early-stage companies may need their hand held as they focus on the science and outsource everything else.” San Diego Business Journal
At Objective Capital Partners, we’re focused on creating innovative strategic guidance and partnership opportunities for these life science companies. David H. Crean, PhD. leads our Life Science and Healthcare Practice Groups. Through his recognized thought-leadership and immersion in these industries, both nationally and locally, it is our mission to help early-stage to established life science companies navigate the challenging waters of maximizing capital raise efforts, business valuation, and strategic partnerships and alliances.
When we partner with life science companies we bring a deep understanding of their business model combined with 50+ years of collective experience to the table. David’s recognition by the San Diego Business Journal and life science community as a leader in this space is evidence of the positive impact we are able to have through our investment banking services for life science companies.
The following is the full article extract from the San Diego Business Journal Life Sciences Issue (May 21, 2018).
